|
Shuttle plasmid for the construction of adenovirus vectors using the AdenoQuick2.0 system (WT E1 region) |
20 µg |
More Info |
|
Shuttle plasmid for the construction of replication-deficient, RCA-free adenovirus vectors using the AdenoQuick2.0 system (E1 deletion) |
20 µg |
More Info |
|
Shuttle plasmid for the construction of conditionally replicative, oncolytic adenovirus vectors (CrAds) using the AdenoQuick2.0 system |
20 µg |
More Info |
|
Shuttle plasmid for the construction of replication-deficient adenovirus vectors using the AdenoQuick2.0 system (E1 deletion) |
20 µg |
More Info |
|
Shuttle plasmid for the construction of conditionally replicative, oncolytic adenovirus vectors (CrAds) using the AdenoQuick2.0 system |
20 µg |
More Info |
|
Shuttle plasmid for the construction of replication-deficient adenovirus vectors using the AdenoQuick2.0 system (E1 deletion with MCS and SV40 polyA signal) |
20 µg |
More Info |
|
Shuttle plasmid for the construction of replication-deficient, RCA-free adenovirus vectors using the AdenoQuick2.0 system (E1 deletion, complete packaging signal) |
20 µg |
More Info |
|
Shuttle plasmid for the construction of adenovirus vectors using the AdenoQuick2.0 system (WT E2 region and late genes) |
20 µg |
More Info |
|
Shuttle plasmid for the construction of adenovirus vectors using the AdenoQuick2.0 system (WT E3 region and fiber) |
20 µg |
More Info |
|
Shuttle plasmid for the construction of adenovirus vectors using the AdenoQuick2.0 system (1.9 kb E3 deletion and WT Ad5 fiber) |
20 µg |
More Info |
|
Shuttle plasmid for the construction of adenovirus vectors using the AdenoQuick2.0 system (2.7 kb E3 deletion and WT Ad5 fiber) |
10 µg |
More Info |
|
Shuttle plasmid for the construction of adenovirus vectors using the AdenoQuick2.0 system (2.7 kb E3 deletion and Ad5/35 fiber) |
20 µg |
More Info |
|
Shuttle vector for the construction of adenovirus vectors using the AdenoQuick2.0 system (WT E4 region) |
20 µg |
More Info |
|
Shuttle plasmid for constructing adenovirus vectors with the E4 region under the control of a heterologous promoter |
20 µg |
More Info |
|
Shuttle plasmid for constructing adenovirus vectors with the E4 region under the control of a heterologous promoter with its own TATA box |
20 µg |
More Info |
